Clinical trial

Psychosomatic Effects of Implantable Cardioverter Defibrillator With Home…

NCT00325221 · Biotronik SE & Co. KG, Industry · Completed

Key facts

NCT number NCT00325221
Title Psychosomatic Effects of Implantable Cardioverter Defibrillator With Home Monitoring Function (QUANTUM)
Official title QUANTUM - Quality-of-Life, Anxiety and Depression in ICD Patients Using Home Monitoring
Lead sponsor Biotronik SE & Co. KG, Industry
Status Completed
Study type Interventional
Conditions Arrhythmia, Quality of Life
Intervention type Device
Interventions HM on, HM Off
Enrollment 148
Start date Aug 1, 2006
Primary completion Jan 1, 2012
Completion Oct 1, 2012
First posted May 12, 2006
Last update posted Jan 31, 2013
Countries Austria, Germany, Switzerland

At a glance

  • 1–9 Study sites
  • No Results posted
  • 1–9 Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies